litlas
Log inCreate account

Charles A. Schiffer

Active 1975–2025

86
Papers
33,231
Citations
79
h-index
86
i10-index

Citations

Citations per year for Charles A. Schiffer1948: 1 citations1976: 3 citations1977: 1 citations1978: 2 citations1979: 4 citations1980: 3 citations1981: 7 citations1982: 7 citations1983: 8 citations1984: 8 citations1986: 5 citations1987: 18 citations1988: 18 citations1989: 17 citations1990: 15 citations1991: 22 citations1992: 13 citations1993: 17 citations1994: 21 citations1995: 31 citations1996: 32 citations1997: 62 citations1998: 76 citations1999: 92 citations2000: 107 citations2001: 165 citations2002: 243 citations2003: 314 citations2004: 272 citations2005: 287 citations2006: 309 citations2007: 255 citations2008: 242 citations2009: 280 citations2010: 271 citations2011: 224 citations2012: 196 citations2013: 214 citations2014: 208 citations2015: 173 citations2016: 178 citations2017: 156 citations2018: 134 citations2019: 494 citations2020: 445 citations2021: 386 citations2022: 321 citations2023: 340 citations2024: 630 citations2025: 246 citations2026: 4 citations1949–1975: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,354 citing papers, 30.1% of this breakdownGermany: 969 citing papers, 8.7% of this breakdownItaly: 744 citing papers, 6.7% of this breakdownUnited Kingdom: 708 citing papers, 6.4% of this breakdownFrance: 668 citing papers, 6% of this breakdownChina: 425 citing papers, 3.8% of this breakdownCanada: 393 citing papers, 3.5% of this breakdownSpain: 367 citing papers, 3.3% of this breakdownNetherlands: 322 citing papers, 2.9% of this breakdownSwitzerland: 292 citing papers, 2.6% of this breakdownAustralia: 261 citing papers, 2.3% of this breakdownJapan: 243 citing papers, 2.2% of this breakdown
0%30.1%Other 21.5%

Institutions

Fields

  • Medicine80%
  • Biochemistry, Genetics and Molecular Biology14.4%
  • Immunology and Microbiology2.2%
  • Health Professions1.2%
  • Materials Science0.4%
  • Computer Science0.4%
  • Other1.4%

Topics

  • Acute Myeloid Leukemia Research16.2%
  • Chronic Myeloid Leukemia Treatments7.7%
  • Acute Lymphoblastic Leukemia research5.4%
  • Chronic Lymphocytic Leukemia Research5.1%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.3%
  • Retinoids in leukemia and cellular processes3.3%
  • Other58%

Coauthors

All papers

Open in search
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Authors: Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström‐Lindberg, Gabriela Hobbs, Ronald Hoffman, Elias Jabbour, Jean‐Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 cited by 2,693

  2. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Authors: Bruce D. Cheson, John M. Bennett, Kenneth J. Kopecky, Thomas Büchner, Cheryl L. Willman, Elihu H. Estey, Charles A. Schiffer, Hartmut Doehner, Martin S. Tallman, Tim Lister, Francesco Lo‐Coco, Roel Willemze, Andrea Biondi, Wolfgang Hiddemann, Richard A. Larson, Bob Löwenberg, Miguel Á. Sanz, David R. Head, R Ohno, Clara D. Bloomfield - Journal of Clinical Oncology 2003 cited by 2,662

  3. Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

    Authors: Jörge E. Cortes, Jane F. Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Arthur, Lori J. Maness, Moshe Talpaz, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael Deininger - Blood 2021 cited by 193

  4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Authors: Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong‐Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman, Rüdiger Hehlmann - Blood 2013 cited by 1,989

  5. Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

    Authors: Lewis R. Silverman, Erin P. Demakos, Bercedis L. Peterson, Alice B. Kornblith, Jimmie C. Holland, Rosalie Odchimar-Reissig, Richard M. Stone, Douglas A. Nelson, Bayard L. Powell, Carlos M. DeCastro, John Ellerton, Richard A. Larson, Charles A. Schiffer, James F. Holland - Journal of Clinical Oncology 2002 cited by 1,813

  6. Acute myeloid leukaemia in adults

    Authors: Felicetto Ferrara, Charles A. Schiffer - The Lancet 2013 cited by 564

  7. All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

    Authors: Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, Angela Ogden, Lois E. Shepherd, Cheryl L. Willman, Clara D. Bloomfield, Jacob M. Rowe, Peter H. Wiernik - New England Journal of Medicine 1997 cited by 1,093

  8. Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: Charles A. Schiffer, Kari Bohlke, Meghan Delaney, Heather Hume, Anthony J. Magdalinski, Jeffrey McCullough, James Omel, John M. Rainey, Paolo Rebulla, Scott D. Rowley, M. Troner, Kenneth C. Anderson - Journal of Clinical Oncology 2017 cited by 343

  9. Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia

    Authors: Ehab Atallah, Charles A. Schiffer, Jerald P. Radich, Kevin P. Weinfurt, Mei-Jie Zhang, Javier Pinilla‐Ibarz, Vamsi Kota, Richard A. Larson, Joseph O. Moore, Michael J. Mauro, Michael W. Deininger, James E. Thompson, Vivian G. Oehler, Martha Wadleigh, Neil P. Shah, Ellen K. Ritchie, Richard T. Silver, Jörge E. Cortes, Li Lin, Alexis Visotcky, Arielle Baim, Jill Harrell, Bret Helton, Mary M. Horowitz, Kathryn E. Flynn - JAMA Oncology 2020 cited by 105

  10. Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

    Authors: Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus, François Guilhot, Charles A. Schiffer, Carlo Gambacorti‐Passerini, Dietger Niederwieser, Debra Resta, Renaud Capdeville, Ulrike Zoellner, Moshe Talpaz, Brian Druker - New England Journal of Medicine 2002 cited by 2,030

  11. Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

    Authors: Robert J. Mayer, Roger B. Davis, Charles A. Schiffer, Deborah Berg, Bayard L. Powell, Philip Schulman, George Omura, Joseph O. Moore, O. Ross McIntyre, E Frei - New England Journal of Medicine 1994 cited by 1,433

  12. 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

    Authors: Thomas J. Smith, James Khatcheressian, Gary H. Lyman, Howard Ozer, Jamés O. Armitage, Lodovico Balducci, Charles L. Bennett, Scott B. Cantor, Jeffrey Crawford, Scott J. Cross, George D. Demetri, Christopher E. Desch, Philip A. Pizzo, Charles A. Schiffer, Lee S. Schwartzberg, Mark R. Somerfield, George Somlo, James C. Wade, James L. Wade, Rodger J. Winn, Antoinette J. Wozniak, Antonio C. Wolff - Journal of Clinical Oncology 2006 cited by 1,644

  13. Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

    Authors: Guido Marcucci, Krzysztof Mrózek, Amy S. Ruppert, Kati Maharry, Jonathan E. Kolitz, Joseph O. Moore, Robert J. Mayer, Mark J. Pettenati, Bayard L. Powell, Colin G. Edwards, Lisa J. Sterling, James W. Vardiman, Charles A. Schiffer, Andrew J. Carroll, Richard A. Larson, Clara D. Bloomfield - Journal of Clinical Oncology 2005 cited by 384

  14. Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Authors: Charles A. Schiffer, Pamela B. Mangu, James C. Wade, Dawn Camp-Sorrell, Diane Cope, Bassel F. El‐Rayes, Mark Gorman, Jennifer A. Ligibel, Paul Mansfield, Mark N. Levine - Journal of Clinical Oncology 2013 cited by 361

  15. Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034

    Authors: Neil P. Shah, Philippe Rousselot, Charles A. Schiffer, Delphine Réa, Jörge E. Cortes, Jorge Milone, Hesham Mohamed, Diane Healey, Hagop M. Kantarjian, Andreas Hochhaus, Giuseppe Saglio - American Journal of Hematology 2016 cited by 181

  16. Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

    Authors: Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei R. Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, Alexander Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani - Blood Advances 2017 cited by 131

  17. Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach

    Authors: Daniel A. Arber, Robert P. Hasserjian, Attilio Orazi, Vikram Mathews, Andrew W. Roberts, Charles A. Schiffer, Anne Stidsholt Roug, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - American Journal of Hematology 2022 cited by 62

  18. Acute myeloid leukemia management and research in 2025

    Authors: Hagop M. Kantarjian, Courtney D. DiNardo, Tapan M. Kadia, Naval Daver, Jessica K. Altman, Eytan M. Stein, Elias Jabbour, Charles A. Schiffer, Amy Lang, Farhad Ravandi - CA A Cancer Journal for Clinicians 2024 cited by 97

  19. Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

    Authors: Kanti R. Rai, Bercedis L. Peterson, Frederick R. Appelbaum, Jonathan E. Kolitz, Laurence Elias, Lois E. Shepherd, John Hines, Gregory A. Threatte, Richard A. Larson, Bruce D. Cheson, Charles A. Schiffer - New England Journal of Medicine 2000 cited by 1,004

  20. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

    Authors: Bruce D. Cheson, Peter A. Cassileth, David R. Head, Charles A. Schiffer, J M Bennett, C. D. Bloomfield, Richard D. Brunning, Gale Rp, Michael R. Grever, Michael J. Keating - Journal of Clinical Oncology 1990 cited by 785

  21. Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

    Authors: Michael Glantz, Suzanne LaFollette, Kurt A. Jaeckle, William Shapiro, Lode J. Swinnen, Jack R. Rozental, Surasak Phuphanich, Lisa R. Rogers, John Gutheil, Tracy T. Batchelor, David W. Lyter, Marc C. Chamberlain, Bernard L. Maria, Charles A. Schiffer, Rifaat Bashir, David M. Thomas, Wayne Cowens, Stephen B. Howell - Journal of Clinical Oncology 1999 cited by 400

  22. Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

    Authors: Richard M. Stone, Thomas Fischer, Ron Paquette, Gary J. Schiller, Charles A. Schiffer, Gerhard Ehninger, Jörge E. Cortes, Hagop M. Kantarjian, Daniel J. DeAngelo, Alice Huntsman-Labed, Catherine Dutreix, Adam del Corral, Francis J. Giles - Leukemia 2012 cited by 273

  23. Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study

    Authors: Neil P. Shah, François Guilhot, Jörge E. Cortes, Charles A. Schiffer, Philipp le Coutre, Tim H. Brümmendorf, Hagop M. Kantarjian, Andreas Hochhaus, Philippe Rousselot, Hesham Mohamed, Diane Healey, Michael E. Cunningham, Giuseppe Saglio - Blood 2014 cited by 196

  24. Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

    Authors: William V. Padula, Richard A. Larson, Stacie B. Dusetzina, Jane F. Apperley, Rüdiger Hehlmann, Michele Baccarani, Ekkehard Eigendorff, Joëlle Guilhot, François Guilhot, Rüdiger Hehlmann, François‐Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin C. Müller, Dietger Niederwieser, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Rena M. Conti - JNCI Journal of the National Cancer Institute 2016 cited by 126